active
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
2 minutes late but here we go.
3:10 can I get a intro?
I hear voices.....
Anyone listening to the conference today besides me?
I hoping they give us some good news in the a.m. before the conference.
Same here guys!!!
Press Release Source: DNAPrint genomics, Inc.
DNAPrint genomics to Present at NYSSA Medical Services Industry Conference on Wed. Sep. 21, 3:10 p.m. Eastern Time
Tuesday September 20, 3:49 pm ET
SARASOTA, Fla., Sept. 20, 2005 (PRIMEZONE) -- DNAPrint genomics, Inc. (OTC BB:DNAG.OB - News) announced today that President and Chief Executive Officer Richard Gabriel will be presenting at the Medical Services Industry Conference sponsored by The New York Society of Security Analysts (NYSSA) on Wednesday, Sept. 21, at The Harvard Club, 27 W. 44th St., in New York City, at 3:10 p.m. Eastern time.
Mr. Gabriel will provide an overview of DNAPrint genomics and its recent activities in the area of pharmacogenomics. Specifically, Mr. Gabriel's presentation will focus on how the Company utilizes recent genomics and chemistry advances to develop next-generation drugs (``theranostics'') maximizing efficacy and minimizing side effects by tailoring medications for specific individuals.
Mr. Gabriel's presentation will be available by means of a live Web cast that can be accessed on the Company's Web site at http://www.dnaprint.com or at http://www.shareholder.com/DNAPrint/medialist.cfm. The Web cast, which includes a PowerPoint presentation, will also be archived.
Those wishing to attend Mr. Gabriel's presentation can register on The New York Society of Security Analysts, Inc., Web site at http://www.nyssa.org/eseries/source/Meetings/ibomeetregister.cfm?PRODUCT_MAJOR=MEDICAL05 . Conference attendees, including mutual and pension fund managers and analysts for the medical services industry, will have an opportunity to hear senior executives discuss the latest developments within the medical services industry sector.
The New York Society of Security Analysts (NYSSA), established in 1937, is a non-profit organization that provides investment professionals a forum for the exchange of ideas and information. Its goals are to inform and educate investors and to advance the professional competence of investment professionals including portfolio managers, security analysts, investment advisors, and others involved in the investment process.
DNAPrint genomics, Inc. (http://www.dnaprint.com) is a developer of genomics-based products and services focused on drug development, pharmacogenomic diagnostic tests, forensics technology and consumer genetic tests. DNAPrint's family of products for the law enforcement forensics and consumer markets include DNAWITNESS, RETINOME, ANCESTRYbyDNA and EURO-DNA.
ADVERTISEMENT
Forward-Looking Statements
All statements in this press release that are not historical are forward-looking statements. Such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including, but not limited to, uncertainties relating to technologies, product development, manufacturing, market acceptance, cost and pricing of DNAPrint's products, dependence on collaborations and partners, regulatory approvals, competition, intellectual property of others, and patent protection and litigation. DNAPrint genomics, Inc. expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in DNAPrint's expectations with regard thereto or any change in events, conditions, or circumstances on which any such statements are based.
Contact:
DNAPrint genomics, Inc.
Richard Gabriel, President and CEO
(941) 366-3400
The Wall Street Group, Inc.
Ron Stabiner
(212) 888-4848
Source: DNAPrint genomics, Inc.
stockboy, I bought more 125k@ .017....
Thank you cosmiclifeform.
Great stuff Gcbr!
That would be nice ExgremeSport.... it's a rough situation we are all in for sure.
I bought antother 120k @ .02 this a.m..... just can't get enough
Wow pre split 2,400,000 !!!
GO SAINTS!!!
Anybody heard what happened here?: http://www.dnaprint.com/welcome/press/press_recent/2005/february_2/
Anybody know what happened here?: http://www.dnaprint.com/welcome/press/press_recent/2005/february_10/
Anybody know what happened here?: http://www.dnaprint.com/welcome/press/press_recent/2005/february_23/
I will buy DNAG and let some one else put their money on the Chiefs.
A real cheese-head.....
Eagles/Colts
GO SAINTS!!!
Press Release Source: SmarTire Systems, Inc.
SmarTire to Present at Arch Investment Conference Sept. 13 in New York City
Thursday September 8, 9:18 am ET
Conference to be Webcast Live
RICHMOND, Canada, Sept. 8 /PRNewswire-FirstCall/ -- SmarTire Systems Inc. (OTC Bulletin Board: SMTR - News) announced today that Chairman Robert Rudman will present at the Arch Investment Conference in New York City, Tuesday, Sept. 13. The conference will be webcast live.
SmarTire is one of six companies presenting at the conference. Rudman is scheduled to present in the morning session from 9 to 10 a.m. The audience will include fund managers, analysts and investment bankers, media and other members of the investment community.
The conference will be webcast live at
http://www.informedinvestors.com/VC/ClientPage.asp?ID=45356 .
About Arch
Arch Investment Conferences, Inc. is an investment conference company that provides services to public small and microcap companies. Arch hosts exclusive events for companies to connect with fund managers, analysts, investment bankers, brokers and other members of the investment community. Arch is not only a bridge to the companies of tomorrow, but to the investment ideas of today. For more information, visit http://www.archconferences.com .
About SmarTire Systems Inc.
SmarTire develops and markets proprietary advanced tire pressure monitoring and technology systems for the global automotive and transportation industries. The U.S. government, through the TREAD Act, has legislated that all new passenger vehicles must be equipped with tire monitoring systems beginning with a phased implementation in 2004. SmarTire is capitalizing on the rapidly emerging OEM and aftermarket opportunities. The company's vision is to become the preeminent provider of wireless sensing and control systems for vehicles worldwide. Incorporated in 1987, SmarTire has offices in North America and Europe.
A comprehensive investment profile regarding SmarTire Systems Inc. may be found at http://www.hawkassociates.com/smartire/profile.htm .
Additional information about SmarTire Systems can be found at http://www.smartire.com . An online investor relations kit containing SmarTire press releases, SEC filings, current Level II price quotes, interactive Java, stock charts and other useful information for investors can be found at http://www.hawkassociates.com and http://www.americanmicrocaps.com . Investors may contact Frank Hawkins or Julie Marshall of Hawk Associates at (305) 451-1888, e-mail: info@hawkassociates.com .
Source: SmarTire Systems, Inc.
Form 8-K for DNAPRINT GENOMICS INC
8-Sep-2005
Entry into Material Agreement, Financial Obligation Matter
Item 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
Amendment to Consulting Agreement with Dr. Arthur Sytkowski
As reported on June 7, 2005, the Registrant entered into a Consulting Agreement (the "Agreement") with Dr. Arthur Sytkowski, the Director of the Beth Israel Deaconess Medical Center, a Massachusetts nonprofit corporation ("Beth Israel") to consult on the development of a new, more potent and longer acting form of the anemia drug Erythropoietin ("EPO"). As reported on April 8, 2005, Beth Israel has granted the Registrant an exclusive license to United States and foreign patents related to certain forms of EPO. The Registrant has the right to develop, use, market and sell products derived from the licensed patents.
On September 1, 2005, the Registrant and Dr. Sytkowski entered into a new Consulting Agreement ("Agreement") amending and restating the June 7, 2005 Consulting Agreement. Under the Agreement, the term has been extended from six
(6) months to one year (August 1, 2005 through July 31, 2006), and the resulting payments from the Registrant to Dr. Sytkowski have increased from a total of $60,000 for six months to a total of $120,000 for one year. The time required to provide notice of cancellation of the Agreement has also been extended from thirty (30) days to ninety (90) days. The Schedule of Activities to be performed by Dr. Sytkowski has also been modified to include additional tasks relating to the development of EPO. The remaining terms of the Agreement are unchanged from the original Consulting Agreement.
Item 2.03 CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT.
See Item 1.01 above.
We're bounciing!!!
Goodness anybody noticing this volume?
Press Release Source: CipherTrust, Inc.
H. Lee Moffitt Cancer Center and Research Institute Finds Remedy for Inbound E-Mail Threats
Wednesday September 7, 9:33 am ET
Leading Cancer Center and Research Facility Fights Scourge of Inbound E-mail Threats with CipherTrust's Award-Winning E-mail Security Appliance
ATLANTA--(BUSINESS WIRE)--Sept. 7, 2005--CipherTrust, Inc., the leader in messaging security, today announced that the H. Lee Moffitt Cancer Center and Research Institute (Moffitt Cancer Center) has selected CipherTrust®'s award-winning IronMail® appliance to protect the company's inbound e-mail traffic. By deploying IronMail, Moffitt Cancer Center is able to protect its more than 3,500 end users from blended threats such as spam, viruses, zombies, intrusions and phishing attacks. In addition, by utilizing CipherTrust's robust policy manager, Moffitt Cancer Center is able to set specific rules to determine whether the inbound mail flow is legitimate.
ADVERTISEMENT
Founded in 1986, Moffitt Cancer Center is a not for-profit institution, and it includes the Southeast's largest Blood and Marrow Transplant Program, outpatient treatment programs that record more than 135,000 visits a year, the Moffitt Research Center, The Moffitt Clinic at Tampa General Hospital, and the Lifetime Cancer Screening Center. Moffitt Cancer Center's mission is to fight cancer effectively through patient care, education and research. With approximately 1,500 physicians, and 1,000 employees and students, Moffitt Cancer Center relies on e-mail to deliver important test results, research data and other mission-critical information. Not only does the Center need to receive its e-mail on time and without interruption from viruses or intruders, it also needs to eliminate the spam messages congesting end-users mailboxes.
"Approximately 75 percent of our inbound e-mail messages per day are spam. As a teaching hospital it is important that we are able to receive messages that contain words such as 'Viagra' or parts of human anatomy that might be part of our legitimate message traffic," said Donald Wasylyna, information security officer at Moffitt Cancer Center. "After evaluating solutions such as MailScan, Tumbleweed and Symantec, we decided to purchase CipherTrust's IronMail to help rid us of our spam problem while at the same time enable us to set rules and policies that permit legitimate mail to make it through, despite some of the words that might be included. IronMail was simple to install and the support has been second to none. Across the board the product delivered everything it said it would and we couldn't be happier."
Since installing the IronMail appliance, Moffitt Cancer Center has greatly reduced spam-related inbound e-mail traffic, thereby reducing administration time removing spam, dealing with false positives and gathering reports. Prior to IronMail, Moffitt administrators would spend between 20 and 30 man hours per week on their previous solution. Since installing IronMail that time has been reduced by approximately 80 percent, and the company is able to manage the overall IT infrastructure proactively without spending excess time managing mail flow. The IronMail infrastructure uses an array of technologies, including anomaly detection, attachment filtering, CipherTrust's patented Message Profiler(TM), Denial-of-Service and buffer overflow protection, and policy enforcement, to examine a wide range of traffic, and pinpoint and block unwanted mail.
"Moffitt Cancer Center selection of IronMail is an aggressive approach toward fighting spam, viruses and other inbound threats," said Jay Chaudhry, CEO and chairman at CipherTrust. "CipherTrust is constantly working with our researchers and customers to determine what new threats are out there in order to prevent vulnerabilities in our customers' networks. CipherTrust is proud to be able to provide Moffitt Cancer Center with an effective means with which to protect its business and education-critical e-mail messages."
About H. Lee Moffitt Cancer Center and Research Institute
In 2001, the National Cancer Institute awarded Moffitt the status of a Comprehensive Cancer Center in recognition of its excellence in research and contributions to clinical trials, prevention and cancer control. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country's leading cancer centers, and is listed in the U.S. News & World Report as one of the top cancer hospitals in America. Moffitt's sole mission is to contribute to the prevention and cure of cancer.
About CipherTrust, Inc.
CipherTrust, Inc., the global market leader in messaging security, provides innovative solutions to stop inbound e-mail threats such as spam, viruses, intrusions, spyware and phishing, and protect against outbound policy and compliance violations. CipherTrust's IronMail, a purpose-built, secure e-mail gateway appliance, defends against threats by combining global intelligence with local behavior analysis via its TrustedSource sender reputation system. IronMail provides integrated best-of-breed capabilities to deliver maximum e-mail availability and unmatched security, effectiveness and enterprise manageability. Recognized by IDC as the market leader, CipherTrust protects 1600 organizations in more than 40 countries worldwide, and is backed by top-tier investors including Battery Ventures and Greylock Partners. For more information about CipherTrust, please visit www.ciphertrust.com or call 877-448-8625.
IronMail and CipherTrust are registered trademarks of CipherTrust, Inc.
Contact:
CipherTrust, Inc.
Joslyn Lyons, 678/904-9279
jlyons@ciphertrust.com
or
Schwartz Communications
Ross Levanto, 781/684-0770
ciphertrust@schwartz-pr.com
or
Moffitt Cancer Center
Donald Wasylyna, 813/745-4515
WasylyD@moffitt.usf.edu
Source: CipherTrust, Inc.
Good morning Miss Scarlet......
Here-here Easy.
Share price rising a little in pre-market....
What do you mean jever00?
I like you jever00... you're consistent!!
Would be nice if you are correct
Maybe the news will come after the bell....
So we are hopiing the rumor is true...
BUY ON THE RUMOR
I hope you are right jever00 I'm holding well over 100k here....
I just bought 30k....
A friend of mine here in Atlanta told me this story today... a secretary at his job had 20 of her family members show up with nothing but the clothes on their backs. People in the office collected 1k from the workers here in Atlanta... what do you think about that?
Thanks everyone for your prayers.
Good morning Miss Scarlet.... thank GOD I'm glad to report all is well with my mother and sisters. They only had minor wind damage and a fallen tree in the yard. My father planted trees around the house... maybe it helped. The home is 45 mies southwest of N.O.
Amen Geob...
Great find Gcbr... let'em argue with those facts!!!
That was a good read Grateful.... thanks!
Thanks... I will.
Yeah they reversed their decision Monday night football is now on....